搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
12 小时
Ever Heard Of A 'Coffee Nap'? It Could Make You Even More Productive And Energized
“Caffeine content varies between beans and brew methods, so be mindful of your daily total,” Sullivan said. Exceeding the ...
MedPage Today
1 天
Fix Your Sleep Naturally: A Doctor Explains
Through my understanding of sleep physiology and the latest scientific research, I have dramatically improved my sleep. I use ...
2 天
Peel-Off Face Masks Are the Most Satisfying Skin Care Products I Own
If you’re on the skin care side of TikTok, there’s a major chance you’ve seen Medicube’s Collagen Night Wrapping Mask. In any ...
Condé Nast Traveler
2 天
Relearning How to Sleep at A Swiss Spa
At Chenot Palace Weggis, new spa programming helps you get your 40 winks and sends you home with some strategies for getting ...
2 天
Is your morning coffee good or bad for your heart? Here’s what the science says
“In short, caffeine, when consumed in moderation, may have benefits for heart health, though high doses can put stress on the ...
来自MSN
2 天
Why Your Morning Coffee Isn’t Working Like It Used To
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
EurekAlert!
3 天
Schematic illustration of Z526's effects on cancer-associated cachexia. (IMAGE)
In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...
Healio
3 天
Blood test uses cyclic adenosine monophosphate to diagnose asthma
Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its ...
4 天
Can-Fite BioPharma secures US patent for Namodenoson
Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.
4 天
Over 15 CD39-Targeted Treatments in Clinical Trials, Market Opportunity Surges by 2025
CD39-Targeted Therapies Near Key Milestones, First Approval Projected by 2029Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market ...
manilatimes
5 天
US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug
The patent application No. 17/309,952 entitled "An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has ...
5 天
Can-Fite BioPharma announces U.S. patent office granted patent to Namodenoson
Can-Fite BioPharma (CANF) announced that its lead drug candidate Namodenoson was granted a patent for its use as an anti-obesity drug by the US ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈